Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Unexpected discovery can open a new chapter in the fight against tuberculosis

Unexpected discovery can open a new chapter in the fight against tuberculosis

June 09, 2009

A close relative of the microorganism that causes tuberculosis in humans has been found to form spores. This is a sensational finding because researchers have long been convinced that these kinds of bacteria-the mycobacteria-were incapable of forming spores. Leif Kirsebom's research group at Uppsala University now has photographic proof, obtained while working with the bacteria that causes tuberculosis in fish, to challenge this long-held belief. Their discovery, which has attracted much attention from other scientists, might constitute a new turn in the fight against human tuberculosis.

"This opens a completely new chapter in mycobacteriology. Now we can perhaps understand how mycobacteria 'hibernate' and cause latent infections," says Leif Kirsebom.




To "hibernate", many types of bacteria generate spores. Anthrax bacteria are a well-known example of this. Spores are stabile and can remain inactive for many years. Bacteria will often form spores when faced with harsh conditions, such as a drastic decrease in nutrition. However, the discovery that mycobacteria can produce spores means that even this group of microorganisms has the ability to "hibernate". The Uppsala research group's pioneering discovery was completely unexpected. In fact, it was the result of a sidetrack in a study on something entirely different, RNA.

"In our studies we noticed something strange that we wondered about, but it wasn't until I received funding to take up a completely new line of research that we took the opportunity to examine more closely the strange finding that we were seeing," says Leif Kirsebom.

The microorganism that causes human tuberculosis, Mycobacterium tuberculosis, was identified in 1882 by the German microbiologist, Robert Koch. Every year ten million new cases of tuberculosis are diagnosed and two to three million people die of the disease. Treatment is difficult because the microorganism is becoming increasingly resistant to antibiotics. It is estimated that a third of the world's population carries the microorganism latently, without any symptoms of the disease.

"This means that the disease can break out much later, even decades after the initial infection," explains Leif Kirsebom.

Little is known about tuberculosis bacteria during this latent stage of the disease. It has been suggested that they are somehow "sleeping" or that their growth is retarded by the infected host's immune system. This lack of knowledge about how they "hibernate" applies to the other kinds mycobacteria as well. Mycobacteria are found everywhere in our environment-in groundwater and tap water, in humans and animals. Besides tuberculosis, they cause many other serious diseases, for example Buruli ulcer and leprosy in humans and Johne's disease in cattle. Even the intestinal disease, Crohn's, is believed to be linked to mycobacteria. The discovery that mycobacteria can form spores opens entirely new avenues to understanding how they "hibernate" and spread.

Uppsala University



Related Tuberculosis Current Events and Tuberculosis News Articles Tuberculosis Current Events and Tuberculosis News RSS Tuberculosis Current Events and Tuberculosis News RSS
There's a speed limit to the pace of evolution, Penn biologists say
Researchers at the University of Pennsylvania have developed a theoretical model that informs the understanding of evolution and determines how quickly an organism will evolve using a catalogue of "evolutionary speed limits."

Cell phones become handheld tools for global development
Mobile phones are on the verge of becoming powerful tools to collect data on many issues, ranging from global health to the environment.

Will genomics help prevent the next pandemic?
This week, the Public Library of Science, an open-access publisher, presents the "Genomics of Emerging Infectious Disease," a collection of essays, perspectives, and reviews that explores how genomics-with all its associated tools and techniques-can provide insights into our understanding of emerging infectious disease.

Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice
An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.

Scientists take step toward simple and portable tuberculosis tests for developing world
Two billion people worldwide carry the pathogen that causes tuberculosis (TB), and most of them do not even know they are infected. This is because some 90 percent of people with TB have "latent" infections. They have no symptoms, they can't spread the disease to others and the bug remains dormant in their lungs -- often for years.

High mortality rates may explain small body size
A new study suggests that high mortality rates in small-bodied people, commonly known as pygmies, may be part of the reason for their small stature.

Iowa State University researcher uncovers potential key to curing tuberculosis
Researchers at Iowa State University have identified an enzyme that helps make tuberculosis resistant to a human's natural defense system. Researchers have also found a method to possibly neutralize that enzyme, which may someday lead to a cure for tuberculosis.

U-M study: Life and death during the Great Depression
The Great Depression had a silver lining: During that hard time, U.S. life expectancy actually increased by 6.2 years, according to a University of Michigan study published in the current issue of the Proceedings of the National Academy of Sciences.

New test quickly ID's active TB in smear-negative patients
Active tuberculosis can be rapidly identified in patients with negative sputum tests by a new method, according to European researchers. Active tuberculosis (TB) is the seventh-leading cause of death worldwide, and while the diagnosis of active TB can be rapidly established when the bacteria can be identified on sputum microscopy, in about half of all cases, the TB bacterium cannot be detected, making another diagnostic option critical in efforts to control the spread of TB.

Weill Cornell Researchers Discover New Anti-Tuberculosis (TB) Compounds
Attempts to eradicate tuberculosis (TB) are stymied by the fact that the disease-causing bacteria have a sophisticated mechanism for surviving dormant in infected cells.
More Tuberculosis Current Events and Tuberculosis News Articles
The White Plague: Tuberculosis, Man and Society

The White Plague: Tuberculosis, Man and Society
by Jean Dubos (Author)



Tuberculosis: A Comprehensive Clinical Reference

Tuberculosis: A Comprehensive Clinical Reference
by H. Simon Schaaf MBChB(Stellenbosch) MMed Paed(Stellenbosch) DCM(Stellenbosch) MD Paed(Stellenbosch) (Editor), Alimuddin I. Zumla BSc MBChB MSc PhD(Lond) FRCP(Lond) FRCP(Edin) (Editor)

This book provides all the vital information you need to know about tuberculosis, especially in the face of drug-resistant strains of the disease. Coverage includes which patient populations face an elevated risk of infection, as well as which therapies are appropriate and how to correctly monitor ongoing treatment so that patients are cured. Properly administer screening tests, interpret their results, and identify manifestations of the disease, with authoritative guidance from expert clinicians from around the world.

Discusses screening tests for tuberculosis so you can interpret their results and identify not only common manifestations of the disease, but also those that are comparatively rare-such as tuberculosis in pregnant women.
Covers all clinical aspects of tuberculosis...

The Forgotten Plague: How the Battle Against Tuberculosis Was Won - And Lost

The Forgotten Plague: How the Battle Against Tuberculosis Was Won - And Lost
by Frank Ryan (Author)

Tuberculosis has claimed more than a billion lives worldwide. In this acclaimed book, Dr. Frank Ryan tells the remarkable story of the dedicated doctors, chemists, and bacteriologists who halted the course of this ferocious disease--until the "old enemy" found in AIDS a deadly ally to form a drug-resistant synergy. 8 pages of photos.

Tuberculosis (TUBERCULOSIS ( ROM))

Tuberculosis (TUBERCULOSIS ( ROM))
by William N Rom (Editor), Stuart M Garay (Editor)

New York Univ., NY. Summarizes the current advances in tuberculosis and discusses the pathology and pathogenesis of the disease. Also covers complications and treatment options. Chapters include history and epidemiology, genomics and microbiology, host response, therapy, and prevention and control. Previous edition: c1996. DNLM: Tuberculosis--Pulmonary.

Historic Tuberculosis Films DVD: History of Pulmonary & Mycobacterium TB & Lung Disease Films

Historic Tuberculosis Films DVD: History of Pulmonary & Mycobacterium TB & Lung Disease Films

Table of Contents: Tuberculosis (1955)11 minutes - This is a fun little film that shows a general history and overview of the effects of tuberculosis on our society. / On the Firing Line (1936) 20 minutes - A fantastic film that has great timeless statistics as well as footage and information about the fight against tuberculosis by the National Tuberculosis Association. / You are the Switchman (1951) 12 minutes running time - A film about noticing the warning signs of cancer and taking appropriate preventative action. You Are the Switchman was a groundbreaking video because it was released two years before the link between smoking cigarettes and cancer was officially out in the open. / City of Hope (1930s) 16 minutes - The Los Angeles Tuberculosis Sanatorium produced this film in the...

Captain of Death: The Story of Tuberculosis

Captain of Death: The Story of Tuberculosis
by Thomas M. Daniel (Author)

The dramatic story of tuberculosis is told here in a straightforward and accessible style. It presents the stories of persons connected with the disease, either as victims, or as those who made contributions to our knowledge of it; in addition to these personal accounts, the book unfolds the history and explains the pathogenesis of TB. The re-emergence of tuberculosis as a major American public health hazard has focused much attention on this ancient disease. This book offers a comprehensive account of the disease from prehistoric times through to the present day, detailing the attempts to eradicate it completely. Its four separate sections (the spread of tuberculosis; its infectious nature; susceptibility to it; and methods of treatment) are linked through the device of presenting...

Tuberculosis (Twenty-First Century Medical Library)

Tuberculosis (Twenty-First Century Medical Library)
by Diane Yancey (Author)

One of the deadliest diseases healthcare workers fight today, tuberculosis (often called TB) infects the lungs of one-third of the world's population and kills about 2 million people a year. While scientific breakthroughs brought this bacterial disease under control during the 1960s to the 1980s, it was never completely eliminated. In the early 1990s, TB came back as a serious global threat. Not only has TB now spread to virtually every country on Earth, new strains of TB--which are resistant to the standard antibiotics used to cure it--have appeared. Learn what causes TB, how it spreads, why it is so difficult to treat, and more in this informative volume.

Handbook of Tuberculosis

Handbook of Tuberculosis
by Stefan H. E. Kaufmann (Editor), Paul van Helden (Editor), Eric Rubin (Editor), Warwick J. Britton (Editor)

Tuberculosis (TB), a deadly airborne disease caused by the bacterium Mycobacterium tuberculosis, takes the lives of almost 2 million people each year and is considered to be the most common infectious disease in the world. However, thanks to the efforts of researchers such as the volumes’ lead editor, Dr. Stefan H. E. Kaufmann, there have been several recent advances in fighting the disease. 

Dr. Stefan Kaufmann, the Founding Director of the Max Planck Institute for Infection Biology in Berlin and Professor of Microbiology and Immunology at the Charité at the Humboldt University, Berlin, has published more than 600 scientific articles and currently serves as President of the European Federation of Immunological Societies and Chair of the Immunology Division of the American...

Living in the Shadow of Death: Tuberculosis and the Social Experience of Illness in American History

Living in the Shadow of Death: Tuberculosis and the Social Experience of Illness in American History
by Sheila M. Rothman (Author)

For more than 150 years, until well into the twentieth century, tuberculosis was the dreaded scourge that AIDS is for us today. Based on the diaries and letters of hundreds of individuals over five generations, Living in the Shadow of Death is the first book to present an intimate and evocative portrait of what it was like for patients as well as families and communities to struggle against this dreaded disease. "Consumption", as it used to be called, is one of the oldest known diseases. But it wasn't until the beginning of the nineteenth century that it became pervasive and feared in the United States, the cause of one out of every five deaths. Consumption crossed all boundaries of geography and social class. How did people afflicted with the disease deal with their fate? How did their...

The Bioarchaeology of Tuberculosis: A Global View on a Reemerging Disease

The Bioarchaeology of Tuberculosis: A Global View on a Reemerging Disease
by CHARLOTTE ROBERTS (Author), JANE BUIKSTRA (Author)

Though apparently in decline during the first half of the 20th century, tuberculosis has reawakened in both developed and developing countries, particularly among susceptible populations with immunodeficiency disorders.

© 2009 BrightSurf.com